Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01522872
Title Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Threshold Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Pacific Cancer Care Monterey California 93940 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Maine Center for Cancer Medicine Scarborough Maine 04074 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
The West Clinic Southaven Mississippi 38671 United States Details
New York Oncology Hematology Albany New York 12208 United States Details
New York Oncology Hematology Hudson New York 12534 United States Details
The West Clinic Memphis Tennessee 38120 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field